"India’s patent office yesterday rejected patent applications for tenofovir and darunavir, leaving the way open for any Indian company to manufacture the drugs, and to export tenofovir to Brazil, where the government has also rejected the patent."
Read more in Aidsmap, September 2, 2009.
0 comments:
Post a Comment